MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.114.014129

Медицинская библиотека · Circulation · 2015

Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin.

Wildi Karin, Gimenez Maria Rubini, Twerenbold Raphael, Reichlin Tobias, Jaeger Cedric, Heinzelmann Amely, Arnold Christiane, Nelles Berit, Druey Sophie, Haaf Philip, Hillinger Petra, Schaerli Nicolas, Kreutzinger Philipp, Tanglay Yunus, Herrmann Thomas, Moreno Weidmann Zoraida, Krivoshei Lian, Freese Michael, Stelzig Claudia, Puelacher Christian, Rentsch Katharina, Osswald Stefan, Mueller Christian

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Misdiagnosis of acute myocardial infarction (AMI) may significantly harm patients and may result from inappropriate clinical decision values (CDVs) for cardiac troponin (cTn) owing to limitations in the current regulatory process.

METHODS AND

RESULTS

In an international, prospective, multicenter study, we quantified the incidence of inconsistencies in the diagnosis of AMI using fully characterized and clinically available high-sensitivity (hs) cTn assays (hs-cTnI, Abbott; hs-cTnT, Roche) among 2300 consecutive patients with suspected AMI. We hypothesized that the approved CDVs for the 2 assays are not biologically equivalent and might therefore contribute to inconsistencies in the diagnosis of AMI. Findings were validated by use of sex-specific CDVs and parallel measurements of other hs-cTnI assays. AMI was the adjudicated diagnosis in 473 patients (21%). Among these, 86 patients (18.2%) had inconsistent diagnoses when the approved uniform CDV was used. When sex-specific CDVs were used, 14.1% of female and 22.7% of male AMI patients had inconsistent diagnoses. Using biologically equivalent CDV reduced inconsistencies to 10% (P<0.001). These findings were confirmed with parallel measurements of other hs-cTn assays. The incidence of inconsistencies was only 7.0% for assays with CDVs that were nearly biologically equivalent. Patients with inconsistent AMI had long-term mortality comparable to that of patients with consistent diagnoses (P=NS) and a trend toward higher long-term mortality than patients diagnosed with unstable angina (P=0.05).

CONCLUSIONS

Currently approved CDVs are not biologically equivalent and contribute to major inconsistencies in the diagnosis of AMI. One of 5 AMI patients will receive a diagnosis other than AMI if managed with the alternative hs-cTn assay.

CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00470587.

Для цитирования: Wildi Karin, Gimenez Maria Rubini, Twerenbold Raphael, Reichlin Tobias, Jaeger Cedric, Heinzelmann Amely, Arnold Christiane, Nelles Berit, Druey Sophie, Haaf Philip, Hillinger Petra, Schaerli Nicolas, Kreutzinger Philipp, Tanglay Yunus, Herrmann Thomas, Moreno Weidmann Zoraida, Krivoshei Lian, Freese Michael, Stelzig Claudia, Puelacher Christian, Rentsch Katharina, Osswald Stefan, Mueller Christian. Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin.. Circulation. 2015. DOI: 10.1161/circulationaha.114.014129.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.